Lateral Flow Assays Market is projected to reach a valuation of US$ 6.9 billion by 2033
The Lateral Flow Assays Market is expected to be worth US$ 4.3 billion in 2023, rising to US$ 6.9 billion by 2033. During the forecast period, lateral flow assay sales are expected to grow at a CAGR of 4.7%. The market profited from the COVID-19 pandemic. The use of lateral flow test kits, which are smaller, portable, and easy to operate, can be more practical than sending patient samples to the lab. This makes them appealing for use in low- and middle-income nations, in countries implementing mass population screening programs, or for deployment outside of healthcare facilities. To learn more about this report @ https://www.futuremarketinsights.com/reports/lateral-flow-assays-market Although less accurate than PCR testing, lateral flow tests are nonetheless popular in nations without large laboratory infrastructure or skilled medical personnel to perform PCR tests due to their affordability, rapidity, and convenience of use. The increasing prevalence of infectious disea...